Denmark And Laguna Niguel

SEATTLE, COPENHAGEN, Denmark and LAGUNA NIGUEL, California, September 20, 2011 - CMC Biologics and Inspiration Biopharmaceuticals ("Inspiration") today announced that the two companies have entered into a long-term commercial supply agreement for the manufacture of bulk IB1001, Inspiration's intravenous recombinant factor IX (rFIX) product, for the treatment and prevention of bleeding in individuals with hemophilia B.